Dr. Ana Baroni is a physician-scientist and longevity strategist with over 25 years of experience in geromedicine, regenerative therapies, and precision health. Holding an MD, PhD, and six MSc degrees, she has led scientific and clinical initiatives across the US, EU, Middle East, and APAC. Her work spans translational aging science, corporate well-being consulting, and tailored healthspan strategies for both terrestrial and space medicine applications.

Dr. Baroni currently serves as Chief Science Officer at Longevitytech.fund and Chief Medical Officer at Healthylongevity.clinic, while advising biotech ventures and government programs on healthy aging and innovation. Dr. Ana Baroni is a professor in the Master’s in Longevity program at Barcelona University and a recognized evaluator for longevity projects under Horizon 2020. Her expertise integrates molecular diagnostics, aging biomarkers, clinical nutrition, and regenerative medicine, with a focus on actionable strategies for health optimization.

Dr. Baroni’s executive education includes programs at INSEAD, Wharton, Harvard, and Oxford, complementing her certifications from A4M and ACBN. She is a published author in nutrigenomics, tissue regeneration, and digital health, and serves on advisory boards including PureHealth UAE. Her multidisciplinary approach empowers startups, institutions, and ecosystems to navigate the future of longevity with scientific rigor and strategic clarity.